A case pending in the Ninth Circuit Court of Appeals highlights the importance of negotiating the term of royalty payments in the license of Food and Drug Administration (FDA)-regulated products. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback